简体中文

Press releases

17 Oct 2022

Milestone Pharmaceuticals Announces Positive Results from Phase 3 RAPID Clinical Trial of Etripamil Nasal Spray in Patients with Paroxysmal Supraventricular Tachycardia

Read article
07 Sep 2022

JIXING Announces the Grand Opening of the New Headquarter Office in China

Read article
26 Aug 2022

JIXING Announces the First Patient Enrolled in China Cohort of Phase 3 Clinical Trial of Aficamten

Read article
22 Jul 2022

JIXING Announces First Patients Enrolled in Phase 3 Clinical Study of OC-01 Nasal Spray in China

Read article
01 Jul 2022

JIXING Announces the First Patient Enrollment in Phase 3 Study of Etripamil in China

Read article
29 Jun 2022

JIXING Announces Receipt of Clinical Trial Application Approval for China Cohort of Phase 3 Clinical Trial of Aficamten

Read article
Load more

Developing innovative cardiometabolic therapies globally

Copyright © 2026 CORXEL. All Rights Reserved.
Designed & built by SampsonMay

沪ICP备20017872号-3

沪公网安备31010602008424号